+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

2019 Muscle Invasive Bladder Cancer Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • ID: 4768245
  • Report
  • 105 pages
  • VPA Research
1 of 4

FEATURED COMPANIES

  • Amgen Inc
  • Argos Therapeutics Inc
  • AstraZeneca Plc
  • Bristol-Myers Squibb Co
  • F. Hoffmann-La Roche Ltd
  • GlaxoSmithKline Plc
  • MORE
The global clinical trial report- “2019 Muscle Invasive Bladder Cancer Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Muscle Invasive Bladder Cancer. It presents in-depth analysis of Muscle Invasive Bladder Cancer clinical trials across markets and companies. The research work is for providing complete understanding into trends in Muscle Invasive Bladder Cancer.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Muscle Invasive Bladder Cancer clinical trials by:
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Muscle Invasive Bladder Cancer

The research work is prepared through extensive and continuous research on Muscle Invasive Bladder Cancer trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Muscle Invasive Bladder Cancer patients are identified
  • The report includes panorama of Muscle Invasive Bladder Cancer clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Muscle Invasive Bladder Cancer clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Amgen Inc
  • Argos Therapeutics Inc
  • AstraZeneca Plc
  • Bristol-Myers Squibb Co
  • F. Hoffmann-La Roche Ltd
  • GlaxoSmithKline Plc
  • MORE
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Muscle Invasive Bladder Cancer Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Muscle Invasive Bladder Cancer Clinical Trials by Region
2.2.2 Average Enrollment of Muscle Invasive Bladder Cancer Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Muscle Invasive Bladder Cancer Treatment, 2019

3. Region wise Muscle Invasive Bladder Cancer Clinical Trials
3.1 Asia Pacific Muscle Invasive Bladder Cancer Clinical Trials by Country
3.2 Europe Muscle Invasive Bladder Cancer Clinical Trials by Country
3.3 North America Muscle Invasive Bladder Cancer Clinical Trials by Country
3.4 Middle East and Africa Muscle Invasive Bladder Cancer Clinical Trials by Country
3.5 South and Central America Muscle Invasive Bladder Cancer Clinical Trials by Country

4. Muscle Invasive Bladder Cancer Clinical Trial Trends
4.1 Start Year wise Muscle Invasive Bladder Cancer Clinical Trials
4.2 Phase wise Muscle Invasive Bladder Cancer Clinical Trials
4.3 Trial Status wise Muscle Invasive Bladder Cancer Clinical Trials
4.4 Trial Type wise Muscle Invasive Bladder Cancer Clinical Trials

5. Muscle Invasive Bladder Cancer Average Enrollment Trends
5.1 Average Enrollment in Muscle Invasive Bladder Cancer Trials by Year
5.2 Average Enrollment in Muscle Invasive Bladder Cancer Trials by Phase
5.3 Average Enrollment in Muscle Invasive Bladder Cancer Trials by Status
5.4 Average Enrollment in Muscle Invasive Bladder Cancer Trials by Type of Trial

6. Companies Participating in Muscle Invasive Bladder Cancer Clinical Trials
6.1 Muscle Invasive Bladder Cancer Trials by Sponsor Type
6.2 Muscle Invasive Bladder Cancer Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Muscle Invasive Bladder Cancer Trials- Phase 1
7.2 Muscle Invasive Bladder Cancer Trials- Phase 2
7.3 Muscle Invasive Bladder Cancer Trials- Phase 3
7.4 Muscle Invasive Bladder Cancer Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Muscle Invasive Bladder Cancer Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Muscle Invasive Bladder Cancer Clinical Trials and Enrolment
Figure 5: Europe - Country wise Muscle Invasive Bladder Cancer Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Muscle Invasive Bladder Cancer Clinical Trials and Enrolment
Figure 7: North America - Country wise Muscle Invasive Bladder Cancer Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Muscle Invasive Bladder Cancer Clinical Trials and Enrolment
Figure 9: Muscle Invasive Bladder Cancer Clinical Trials by Phase
Figure 10: Muscle Invasive Bladder Cancer Clinical Trials by Trial Status
Figure 11: Muscle Invasive Bladder Cancer Clinical Trials by Type
Figure 12: Muscle Invasive Bladder Cancer Clinical Trials by Sponsor Type
Figure 13: Muscle Invasive Bladder Cancer Clinical Trials by Leading Sponsors
Figure 14: Muscle Invasive Bladder Cancer Average Enrollment by Phase
Figure 15: Muscle Invasive Bladder Cancer Average Enrollment by Trial Status
Figure 16: Muscle Invasive Bladder Cancer Average Enrollment by Type
Figure 17: Muscle Invasive Bladder Cancer- Average Enrolment by Type of Sponsors
Figure 18: Muscle Invasive Bladder Cancer- Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: Muscle Invasive Bladder Cancer Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Muscle Invasive Bladder Cancer Clinical Trials and Enrolment
Table 5: Europe - Country wise Muscle Invasive Bladder Cancer Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Muscle Invasive Bladder Cancer Clinical Trials and Enrolment
Table 7: North America - Country wise Muscle Invasive Bladder Cancer Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Muscle Invasive Bladder Cancer Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Muscle Invasive Bladder Cancer Average Enrollment by Phase
Table 15: Muscle Invasive Bladder Cancer Average Enrollment by Trial Status
Table 16: Muscle Invasive Bladder Cancer Average Enrollment by Type
Table 17: Muscle Invasive Bladder Cancer- Average Enrolment by Type of Sponsors
Table 18: Muscle Invasive Bladder Cancer- Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Amgen Inc
  • Argos Therapeutics Inc
  • AstraZeneca Plc
  • Bristol-Myers Squibb Co
  • F. Hoffmann-La Roche Ltd
  • GlaxoSmithKline Plc
  • Merck & Co Inc
  • Sanofi
  • Taris Biomedical LLC
  • UroGen Pharmaceuticals Ltd
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4768245
Adroll
adroll